[wgolsen]

In my opinion, and it seems in the NPR editor’s opinion, the most exciting angle to this story isn’t the cure of one relatively rare disease (TAA), but rather the seemingly imminent cure of many/most inherited diseases which affect cells of the liver. Indeed, we can even make edits that confer protective benefits to people at risk for diseases due to mutations OR lifestyle (see a similar approach by Verve Therapeutics). This is a big story which deserves the attention grabbing headline.